Results 181 to 190 of about 42,544 (264)

Machine learning prediction of functional cure to pegylated interferon-alpha therapy in two HBV populations: Advantaged populations and HBeAg-negative patients. [PDF]

Virulence
Li J, Li H, Lin C, Jiang R, Wang L, He Y, Yang X, Gong K, Xun Z, Zheng Q.   +9 more
europepmc   +1 more source

Lead Optimization of Xanthone Derivatives as Hepatitis B Virus cccDNA Reducers: Design, Synthesis, and Bioevaluation. [PDF]

ACS Med Chem Lett
Guo L, Chen X, Liu X, Liu N, Sun K, Hong H, Zhao D.   +6 more
europepmc   +1 more source

Immunochemical characteristics of hepatitis Be antigen subspecificties, HBeAg/1 and HBeAg/2

, 1988
openaire   +1 more source

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. [PDF]

Front Immunol
Zhu C, Yang J, Sheng Y, Fang M.
europepmc   +1 more source

Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.

Journal of Antimicrobial Chemotherapy, 2015
M. Machaira, V. Papaevangelou, E. Vouloumanou, G. Tansarli, M. Falagas   +4 more
semanticscholar   +1 more source

Beyond viral suppression: combining PEG-interferon with novel immunotherapies for functional cure of chronic hepatitis B. [PDF]

Front Cell Infect Microbiol
Wang Q, Deng W, Wang S, Cao W, Li X, Zhang Z, Xie Y, Xing H, Li M.   +8 more
europepmc   +1 more source

Sustained HBsAg clearance induced by pegylated interferon α-2b in HBeAg-negative patients with low baseline HBsAg. [PDF]

Front Cell Infect Microbiol
Wen C, He T, Zha G, Li A, Wang Z, Zhou Z, Cai D, Zhang D, Peng M, Shi X, Ren H.   +10 more
europepmc   +1 more source

ENPP1 and IFIT2 in PBMCs as early predictive biomarkers for HBsAg clearance and responses to Peg-IFN-α in HBeAg-negative chronic hepatitis B patients. [PDF]

Front Immunol
Pang H, Fu X, Jiang J, Qin B.
europepmc   +1 more source

Accuracy of Diagnostic Investigations in Monitoring Hepatitis B Virus Infection: Strengths, Limitations, and Emerging Biomarkers. [PDF]

Int J Mol Sci
Bozomitu LI, Lupu A, Lupu VV, Gimiga N, Anton Paduraru DT, Mîndru DE, Mihai M, Anton C, Anton E, Mitrea M, Adam-Raileanu A, Forna L.   +11 more
europepmc   +1 more source

Heterogeneity Analysis of HBeAg-Positive Chronic Hepatitis B Patients with Ultra-High Viral Load (HBV DNA ≥ 7.0 log₁₀ IU/mL). [PDF]

J Clin Med
Li G, Ren R, Liu J, Li J.
europepmc   +1 more source